Cargando…
Somatostatin receptors 2 and 5 are preferentially expressed in proliferating endothelium
Angiogenesis is characterised by activation, migration and proliferation of endothelial cells and is central to the pathology of cancer, cardiovascular disease and chronic inflammation. Somatostatin is an inhibitory polypeptide that acts through five receptors (sst 1, 2, 3, 4, 5). Sst has previously...
Autores principales: | Adams, R L, Adams, I P, Lindow, S W, Zhong, W, Atkin, S L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362009/ https://www.ncbi.nlm.nih.gov/pubmed/15812556 http://dx.doi.org/10.1038/sj.bjc.6602503 |
Ejemplares similares
-
Expression of somatostatin receptors 2 and 5 in circulating tumour cells from patients with neuroendocrine tumours
por: Childs, Alexa, et al.
Publicado: (2016) -
Localisation of somatostatin and somatostatin receptors in benign and malignant ovarian tumours
por: Hall, G H, et al.
Publicado: (2002) -
Nutlin-3 preferentially sensitises wild-type p53-expressing cancer cells to DR5-selective TRAIL over rhTRAIL
por: Meijer, A, et al.
Publicado: (2013) -
Somatostatin Receptor 1, a novel EBV-associated CpG hypermethylated gene, contributes to the pathogenesis of EBV-associated gastric cancer
por: Zhao, J, et al.
Publicado: (2013) -
Proliferation, steroid receptors and clinical/pathological response in breast cancer treated with letrozole
por: Miller, W R, et al.
Publicado: (2006)